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1. Introduction  
Reproduction is an essential function of every animal species, and its realization depends on 
a complex of interrelated neural, endocrine, immune, and behavioral reactions. It is now 
accepted that the neuroendocrine system (including its reproductive component) and the 
immune system have a reciprocal regulatory influence development and functioning during 
pre- and postnatal ontogeny (Watanobe & Hayakawa, 2003; Zakharova et al., 2005; Carreras 
et al., 2008; Li et al., 2007; Chapman et al., 2009; Wu et al., 2011). The functions of these 
systems change during ontogeny. In the perinatal period, they are involved not only in 
regulatory but also in morphogenetic processes, unlike in the postnatal period. The tight 
bilateral connection between these systems is of special significance during the early, critical 
period of ontogeny, when the functions necessary for postnatal life of newborns are being 
established. The key role in the interaction of the reproductive and immune systems is 
played by the hypothalamic neuropeptide gonadotropin-releasing hormone (GnRH) and sex 
hormones. During the perinatal period, they regulate the growth and differentiation of 
various fetal tissues, including the lymphoid tissue. In postnatal life, the dynamics of 
endocrine processes related to reproduction are regulated by the level of GnRH secretion 
into the hypothalamo-pituitary portal circulation. GnRH regulates secretion of pituitary 
gonadotropins, which regulate secretion of sex hormones. GnRH is also involved in 
regulation of sexual behavior, transmission of olfactory signals, and control of humoral and 
cell-mediated immunity. Sex hormones, in turn, regulate GnRH production in the 
hypothalamus (and, therefore, secretion of pituitary gonadotropins) and also its production 
in the thymus and spleen (Azad et al, 1998; Hrabovszky et al., 2000). On the other hand, 
immune system mediators such as thymic peptides and proinflammatory cytokines have a 
role in controlling the development and functioning of the reproductive system. 
Interactions of the reproductive and immune systems during early ontogeny are 
prerequisite to their normal functioning in adult life. Changes in the normal levels of GnRH 
and sex steroids in the developing fetus or newborn and their exposure to adverse 
environmental factors cause disturbances in long-term programming of the regulatory 
mechanisms of both reproductive and immune systems (Jacobson et al., 2000; Razia et al., 
2006; Cameron et al., 2008; Champagne & Curley, 2008). The brain is especially sensitive to 
perinatal programming by sex steroids, which not only contribute to the patterning of brain 
www.intechopen.com
 
Sex Steroids 
 
222 
structures during early ontogeny but also activate sexual behavior in prepubertal and 
pubertal males and females. Thus, the brain retains its plasticity for programming at later 
stages of ontogeny, being most responsive to sex steroids in adolescence as well as in the 
perinatal period (Shulz et al., 2009). The formation of individual structural–functional 
elements of the reproductive and immune systems and the establishment of relationships 
between them are not strictly genetically controlled. These processes are characterized by 
high functional lability and sensitivity to various regulatory factors, which provides the 
possibility of correcting disturbances in the reproductive process.  
2. Effect of the reproductive system on the immune system: Roles of GnRH 
and sex steroids  
Distinctive features of GnRH-producing neurons include their small population size (800–
2000 cells), diffuse distribution in the septo-preoptic hypothalamic region, and extracerebral 
origin during ontogeny. Most these neurons have axons terminating in the median 
eminence, where GnRH is released in the portal circulation and regulates the synthesis and 
secretion of the luteinizing hormone (LH) and follicle-stimulating hormone (FSH) by 
gonadotrope cells. GnRH isolated from the mammalian brain was initially regarded only as 
the hormone controlling the reproductive function, but subsequent studies have 
demonstrated that GnRH occurs in a variety of functionally different forms. To date, 23 such 
forms have been identified in vertebrates. Three of them—GnRH1, GnRH2, and GnRH3—
are the most frequent, being expressed in groups of neurons differing in origin, location, and 
functional role. In adult animals, GnRH1 is expressed mainly in the hypothalamus; GnRH2, 
in the midbrain and tectum; and GnRH3, in the rostral regions of the forebrain. The 
population of hypothalamic neurons expressing GnRH1 is usually referred to as the GnRH1 
system, and its basic function is to regulate the release of gonadotropins. GnRH2 and 
GnRH3 supposedly function as neuromodulators, the former being involved in the 
regulation of sexual behavior and the latter, in the integration of olfactory signals and other 
processes related to reproduction. Extracerebral synthesis is characteristic mainly of GnRH2, 
which has been revealed in the thymus, spleen, ovaries, testes, prostate, mammary gland, 
and placenta (Jacobson et al., 2000; Zakharova et al., 2005). Along with hypothalamic GnRH, 
extracerebral GnRH2 plays a role in the development and functioning of the immune system 
at different stages of ontogeny (Morale et al., 1991; Zakharova et al., 2005). According to 
Marchetti et al. (1998), GnRH is one of the most important signal molecules involved in the 
neuroendocrine–immune interaction.  
Sex steroids, in turn, control the development and functioning of the hypothalamo-pituitary 
and immune systems. In particular, they account for the programming of sexual 
dimorphism in the structure and functions of the hypothalamo-pituitary system of 
vertebrates and regulate GnRH production in the hypothalamus and expression of GnRH 
receptors in the pituitary, thereby modulating the response of gonadotrope cells to this 
hormone. Sex steroids also modulate the molecular processing of GnRH in the thymus and 
its concentrations in the thymus and spleen (Azad et al, 1998).  
The effects of these hormones on the immune and endocrine systems apparently differ 
depending on the period of ontogeny, as is the case with many other factors. During the 
early period, they cause long-lasting or irreversible changes in the structure and functions of 
the above systems, whereas their effects in adult animals are short-term and reversible. 
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2.1 Role of GnRH in immune system development and functioning at different stages 
of ontogeny 
The involvement of GnRH in the differentiation of lymphocytes and regulation of immune 
response is lifelong. Its neonatal administration in normal mice accelerates the development 
of immune reactions (Marchetti et al., 1989). In rats and monkeys, central or peripheral 
blockade of the GnRH receptor antagonists in the neonatal period leads to reduction of mature 
T- and B-lymphocyte counts in the thymus, spleen, and circulating blood and suppression of 
antibody production and mitogen-induced proliferative response of T cells, with the immune 
reactions returning to the norm only by the age of 3 months in rats and 5 years in monkeys 
(Morale et al., 1991). Thymic and splenic lymphocytes differ in sensitivity to GnRH. Neonatal 
administration of a GnRH antagonist in rats results in complete block of the mitogen-induced 
proliferative response of thymocytes, whereas this response of splenocytes is blocked only 
partially. GnRH and its agonists prevent age-related involution of the thymus and normalize 
the suppressed functional activity of thymocytes (Marchetti et al., 1989). In pregnancy, the 
functional activity of GnRH in controlling the numbers of thymocytes is suppressed due to the 
intensified synthesis of prohibitin, an antiproliferative protein; as a consequence, the maternal 
thymus undergoes involution. The suppression of T-lymphocyte development in pregnancy is 
an adaptation against allogeneic fetal rejection. Administration of an GnRH agonist results in 
normalization of thymocyte count (Dixit et al., 2003). 
There is evidence that GnRH exacerbates progression of autoimmune diseases. In particular, 
this follows (by contradiction) from the data by Jacobson et al. (2000) that administration of 
an GnRH antagonist to New Zealand mice with systemic lupus erythematosus leads to a 
drop in the levels of both total IgG and anti-DNA antibodies, relief of disease symptoms, 
and extension of life span, with these effects being observed in both intact and castrated 
animals of both sexes. It should be noted that the diseases progresses more severely in 
females than males, which the authors attribute to sex-related differences in the expression 
of GnRH receptors or G protein (Jacobson et al., 2000). Although the available data on the 
involvement of GnRH in immune response modulation and exacerbation of autoimmune 
diseases in adults are fairly abundant, its role in these processes is not yet completely clear. 
However, since the functions of many hormones in postnatal life are aimed at the 
maintenance of immune system homeostasis in response to changes in ambient conditions 
(Dorshkind & Horseman, 2000), such a function cannot be excluded for GnRH. 
According to our data (Zakharova et al., 2000), GnRH becomes involved in the regulation of 
T-cell immunity as early as during prenatal ontogeny. Surgical ablation of the hypothalamus 
(encephalectomy) in utero in 18-day rat fetuses results in 30–40% suppression of 
concanavalin A (Con A)-induced response in thymocytes isolated on day 22, but 
intraperitoneal injection of GnRH (0.2 μg per fetus) immediately after surgery restores this 
response to the norm. No such effect has been observed in experiments with sham-operated 
fetuses. Moreover, GnRH (10–9 and 10–7 M) added to a culture of thymocytes from 
encephalectomized fetuses has proved to enhance their Con A-induced proliferative 
response in a dose-dependent manner. The involvement of GnRH at early stages of immune 
system development is also confirmed by the results of experiments on central or peripheral 
blockade of the synthesis of GnRH or its receptors in rat fetuses (Zakharova et al., 2005). On 
day 20 of pregnancy, fetuses in one uterine horn were intraperitoneally injected with either 
the selective GnRH antagonist D-pGlu-D-Phe-D-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2 
or anti-GnRH antibodies, and fetuses in the other horn, with 0.9% NaCl solution or 
nonimmune rabbit serum. The GnRH antagonist (2 μg per fetus) caused 40–50% 
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suppression of Con A-induced proliferative response of thymocyte on day 22, compared to 
that in fetuses injected with saline (0.9% NaCl). It should be noted that this response did not 
differ between male and female fetuses, either in the norm or after the antagonist injection. 
When thymocytes from 22-day fetuses were cultured in the presence of the GnRH 
antagonist (10–5 or 10–6 М), no such decrease in the proliferative response was observed. In 
the case of injection with anti-GnRH antibodies, Con A-induced proliferative response of 
thymocytes was suppressed fivefold, compared to that in fetuses injected with either saline 
or nonimmune serum. 
On the other hand, the injection of a long-acting GnRH agonist to prepubertal female mice 
has been found to suppress T- and B-cell maturation in the primary lymphoid organs. It 
appears that GnRH acts on lymphocyte precursors so that changes in its initial concentration 
lead to suppression of their differentiation in the central organs of the immune system (the 
thymus and bone marrow), which, in turn, accounts for the decreased numbers of 
differentiated T and B cells in spleen, a secondary lymphoid organ (Rao et al., 1995).  
The synthesis of GnRH and its receptors in the thymus and spleen of adult animals has been 
confirmed experimentally. As shown by Azad et al. (1997), the Jurkat human leukemia T-cell 
line (phenotypically similar to normal human T lymphocytes) expresses GnRH mRNA and 
secretes this hormone and its precursor into the culture medium. The proliferative activity 
of these cells increases under the effect of either endogenous or exogenous GnRH, whereas 
its antagonist suppresses their proliferation. According to the same authors (Azad et al., 
1998), the concentration of GnRH in the thymus significantly increases in castrated rats, but 
this increase is prevented by testosterone injection. It is considered that sex steroids 
modulate molecular processing of the GnRH precursor, with its processing in the thymus 
differing from that in the hypothalamus. 
The results of our experiments exhibit that GnRH is also synthesized in the fetal thymus 
(Zakharova et al., 2005). Immunocytochemical analysis for GnRH in the thymus of 21-day 
rat fetuses revealed the presence of GnRH-positive cells morphologically identical to 
thymocytes. Quantitative assessment of GnRH in the thymus exhibited that its content was 
minimal in 18-day fetuses, increased by a factor of about 1.5 in 21-day fetuses, and further 
increased by postnatal day 3 (by 65 and 40%, compared to intrauterine days 18 and 21), 
reaching the level characteristic of the hypothalamus. The GnRH contents in the thymus 
were similar in males and females. A considerable GnRH level was also detected in the 
blood serum of rat fetuses. It reached a peak in 18-day fetuses and decreased by half in 21-
day fetuses, remaining fairly high relative to those in the thymus and hypothalamus. After 
surgical ablation of the hypothalamus (encephalectomy) on intrauterine day 18, the 
concentrations of GnRH in the thymus and peripheral blood of 21-day fetuses, either male 
or female, was half as low as in sham-operated fetuses. The origin of circulating GnRH is as 
yet unclear. Since its level drops after encephalectomy, it appears that at least half its 
amount is of brain origin and, therefore, the level of this hormone at the periphery is 
controlled by the hypothalamus. It cannot be excluded, however, that GnRH found in the 
circulating blood of fetuses comes from other sources (e.g., the placenta). 
All the above data suggest that GnRH can control the development and functioning of the 
immune system via the hypothalamo-pituitary axis and is involved in an autocrine or 
paracrine regulation of the immune response during postnatal life. There are several 
possible mechanisms of GnRH action on the immune system: it can interact with specific 
receptors on thymic epithelial cells that synthesize peptides participating in T-cell 
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maturation, as well as directly interact with such receptors on lymphocytes. In addition, 
GnRH can induce both the expression of interleukin (IL)-2 receptors on lymphocytes and the 
synthesis of gamma-interferon (IFNǄ), which, in turn, induces IL-2 production by T cells, 
thereby regulating their numbers (Grasso et al., 1998).  
2.2 Role of sex steroids in the development of immune and endocrine systems  
During early ontogeny, sex hormones (along with other hormones) participate in the 
development of the hypothalamo-pituitary and immune systems. It is known that exposure 
of the fetus to adverse factors can affect the structural and functional programming of these 
systems, with consequent disease susceptibility in adulthood (Langley-Evans, 2006). 
Alterations in a certain developing system usually entail alterations in other systems. 
External factors such as stress, treatment with pharmaceuticals, and mother's inadequate 
diet and behavior during pregnancy and breast feeding place the fetus (newborn) at risk for 
autoimmune, allergic, metabolic, nervous, and mental disorders in later life (Fowden & 
Forhead, 2004; Wang et al., 2009; Wu et al., 2011).  
A strong stimulus changing homeostasis of the fetus is exerted by sex steroids. The 
mechanisms of sexual differentiation of the brain were addressed even in the first studies on 
prenatal programming of the GnRH system. It has been shown long ago that the 
development of the brain in male mammals initially follows the female pattern, but specific 
brain regions in a certain period of ontogeny are influenced by testosterone aromatized into 
estradiol, which leads to masculinization of the brain and its subsequent development 
according to the male scenario. This period is critical for organization of the GnRH system, 
and its timing varies between species. In rodents, brain masculinization takes place during 
the late intrauterine–early postnatal period; in guinea pigs, during midpregnancy; in rhesus 
monkeys and humans, this process is accomplished by the second trimester of pregnancy; 
whereas in sheep it continues from days 30--37 to 147 of intrauterine development.  
An increase in the concentration of androgens in mice between intrauterine day 18 and 
postnatal day 14 causes changes in the development of the hypothalamo-pituitary system. 
Male transgenic hCGǂǃ+ mice overproducing human chorionic gonadotropin are 
characterized by an elevated GnRH level in the hypothalamus, a reduced FSH level in the 
pituitary and circulating blood, and inhibited expression of the mRNA of receptors for 
GnRH and estrogens in the pituitary (Gonzalez et al., 2011). The sexual behavior of a 
pregnant female has an effect on the functioning of the endocrine system in its offspring, 
which is mediated by epigenetic modifications at the promoter for oestrogen receptor alpha 
(ER) and subsequent effects on gene expression (Cameron et al., 2008). Estradiol and 
testosterone injected to female mice during the neonatal period induce the development of 
infertility, whereas their injection on postnatal day 7 causes no disturbances in the 
reproductive system. Hydrocortisone injected together with estradiol prevents the 
development of infertility (Chapman et al., 2009).  
Sex hormones also modulate the development of lymphoid organs, the thymus being their 
main target in the immune system. The drop in the level of sex hormones in male mice after 
pre- or postpubertal castration causes thymic hypertrophy (with increase in thymocyte 
count) and enhancement of graft rejection reaction. The phenomenon of twofold increase in 
thymus weight in castrated males was discovered more than a century ago, but its 
mechanism has not yet been elucidated in detail. Injection of androgens to castrated animals 
results in a rapid decrease in thymus weight, with signs of active apoptosis being observed 
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in the organ. The effects of androgens are realized via traditional receptor-mediated 
mechanisms (Olsen et al., 1996). Receptors for estrogens and androgens in the thymus are 
expressed as early as during embryonic development, with their level increasing by birth 
(Staples et al., 1999). Thymocytes carry the same numbers of functional androgen receptors 
as do target cells for these hormones in the reproductive system, with the least mature 
thymocyte subpopulations being the richest in such receptors. The thymic stroma also 
expresses androgen receptors. Estrogen receptors are expressed on mature peripheral T and 
B lymphocytes, which mediate the immunomodulatory effects of sex hormones (Tanriverdi 
et al., 2003. 
Injection of testosterone, estrogen, or their derivatives to chick or quail embryos results in 
atrophy of the bursa of Fabricius, degeneration of lymphoid tissue in follicles and its 
substitution by fibrous tissue, and disturbances in the development of thymic stromal 
elements creating the microenvironment for lymphocyte maturation (Razia et al., 2006). In 
addition, excess sex steroids cause disturbances in mammal immune system. In particular, 
they suppress differentiation of regulatory and cytotoxic T cells in the thymus, with 
consequent increase in the numbers of immature lymphocytes in the circulation, and cause 
an impairment of negative selection mechanisms, which results in the formation of self-
reactive T cells (Chapman et al., 2009). Estrogens also stimulate an increase in the numbers 
of self-reactive B lymphocytes and the level of circulating autoantibodies (Olsen & Kovacs, 
1996; Tanriverdi et al., 2003). These data are in agreement with the observation that females, 
especially when pregnant, are more vulnerable to autoimmune diseases, compared to males. 
On the other hand, it has been noted that the level of testosterone in male mice genetically 
resistant to infectious diseases is maintained high after infection with bacterial (Salmonella 
enteritis) endotoxin, whereas this level in sensitive males dropped significantly on day 14 
after infection (Zala et al., 2008). 
Female mice kept at high density in the presence of only one male in the cage become 
aggressive, unresponsive to mating attempts and do not copulate. The aggressive behavior of 
females correlates with elevated levels of testosterone, corticosterone, and progesterone. 
Compared to female mice kept under standard conditions, the weight of their ovaries and 
adrenals is greater, while that of the thymus and uterus is smaller, and the lysis of corpora 
lutea in the ovaries is prolonged and incomplete. Supposedly, high corticosterone suppresses 
the activity of T lymphocytes normally involved in this process (Chapman et al., 2000).  
Despite general similarity in the effects of male and female sex hormones on the thymus, the 
resultant changes in the composition of cell subpopulations in this organ are different: 
estrogens cause a decrease in the number of cortical T lymphocytes and an increase in the 
contents of more mature cell forms, whereas androgens have an opposite effect (Olsen and 
Kovacs, 1996). 
Sex hormones also regulate the development of bone tissue and bone marrow and have an 
immunomodulatory effect on B lymphocytes in adults. Estrogens control differentiation of 
osteoclasts, mesenchymal stem cells, and myelopoiesis in the bone marrow (Carreras et al., 
2008). Interacting with receptors on bone marrow stromal cells, sex hormones modulate B-
cell differentiation. In either males or females, castration results in the increased numbers of 
pre-B cells in the bone marrow and mature B cells in peripheral organs, with the spleen 
growing in size (Olsen et al., 1996). In pregnancy, at a high estrogen background, the relative 
numbers of B lymphocytes in the bone marrow are decreased at almost all stages of 
differentiation (Tanriverdi et al., 2003). 
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Estrogens have a protective effect on the progression of autoimmune diseases, in particular, 
multiple sclerosis and autoimmune encephalomyelitis as its model. In pregnant women 
with multiple sclerosis, clinical remission is observed during the last trimester, at a high 
level of estrogens and progesterone; after delivery, this level drops, and the disease is 
exacerbated. Exogenous estrogens at physiological concentrations suppress the progression 
of experimental encephalomyelitis, supposedly by inhibiting the synthesis of 
proinflammatory cytokines (Van den Broek et al., 2005). The protective effect of sex steroids 
is dependent on a number of factors, including their dose and the age, sex, and metabolic 
pattern of animals. Thus, in NZB/NZW mice, which spontaneously develop lethal 
glomerulonephritis by the age of 8–14 months, castration of 14-day-old females 
accompanied by testosterone injection significantly prolongs their life span. On the other 
hand, castration and estradiol injection in males has an opposite effect. Moreover, males 
castrated at the age of 14 days die of this disease earlier than do males castrated at the age of 
5 weeks, while castration of 14- to 15-week-old males has no effect on their life span. 
It is noteworthy that the patterning of sexual behavior by sex steroids takes place not only 
during early ontogeny. As noted above, the brain retains its plasticity at later stages, and its 
responsiveness to sex steroids in males reaches a second peak during adolescence. Such a 
peak during the late postnatal period is also characteristic of females, but its exact timing 
has not yet been determined for them (Shulz et al., 2009).  
2.3 Effect of immune system on the development of reproductive system: Role of 
cytokines and thymic peptides  
Numerous data are available on the effect of the neuroendocrine system, including its 
reproductive component, on the establishment and functioning of the immune system. The 
immune system, in turn, is not only the target for hormones but is itself involved in the 
regulation of neuroendocrine system functioning. Mediators produced by the immune 
system have a role in programming the development of reproductive system in the fetus 
(Igaz et al., 2006; Li et al., 2007; Goya et al., 2004). The thymus is the central organ of the 
immune system, and its absence in homozygous athymic or neonatally thymectomized mice 
leads to severe disturbances in immune–neuroendocrine regulation. These disturbances 
manifest themselves not only in the inhibited functions of the immune system but also in the 
impaired synthesis and secretion of neuropeptides and hormones of the hypothalamus, 
pituitary, and peripheral endocrine glands (Goya et al, 2004; Chapman et al., 2009; 
Zakharova, 2009). The impaired neuroendocrine functions can be modulated by thymic 
peptides (Goya et al., 2007). There is evidence that bacterial endotoxins and 
proinflammatory cytokines have influence on the GnRH system of newborns (Li et al., 2007). 
In particular, neonatal activation of the immune system by these factors results in long-term 
sensitization of the adult GnRH system to the inhibitory effect of stress.  
2.3.1 Regulation of the GnRH system in adult mammals 
As noted above, GnRH has a modulatory effect on the development and functions of the 
neuroendocrine and immune systems, which, in turn, control the functioning of the GnRH 
system. It is through GnRH neurons that various neurotransmitters and neuropeptides 
(monoamines, gamma-aminobutyric acid, neuropeptide Y, opioids, tec.) and also cytokines 
convey signals from external stimuli influencing the state of the reproductive system 
(Karsch et al., 2002; Ciechanowska et al., 2007; Pereira A et al., 2010). Sex steroids are the 
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most powerful regulators of the GnRH system. During the estrous cycle, for example, the 
GnRH level in the anterior pituitary varies in antiphase to the level of plasma estrogens, 
with estradiol having been shown to reduce the content of GnRH mRNA in this pituitary 
region. On the other hand, estradiol increases the level of GnRH in the hypothalamus 
immediately before ovulation. It has long been considered that sex steroid exert their effect 
through steroid-sensitive sites of the brain, because no specific receptors have been found on 
GnRH neurons. However, this concept was questioned after identification of estrogen-
sensitive regions in the promoter of human GnRH gene and estrogen receptors ER and 
ER on cells of mouse GnRH neuronal cell line GT1-7 expressing the rat GnRH gene. Using 
improved techniques of in situ hybridization and binding of a radioactive estrogen analog, it 
has been shown that at least part of GnRH neurons in rats contain ERǃ-receptor mRNA and 
can bind the radioactive estradiol analog (Hrabovszky et al., 2000). Estradiol and 
progesterone regulate the expression of receptors for GnRH on gonadotrope cells. 
Progesterone also regulates GnRH secretion depending on the physiological body state. 
Before ovulation, it activates GnRH neurons and stimulates its secretion. After ovulation, in 
the luteal phase of the estrous cycle, corpus luteum enhances progesterone synthesis in 
preparation for probable zygote implantation; under such conditions, progesterone inhibits 
the pulse secretion of GnRH.  
Long-term studies on the complex pathways of sex steroid action on GnRH neurons have 
shown that they involve various neurotransmitter systems operating in different brain 
regions of adult mammals. In rodents, the main steroid-sensitive brain region is the preoptic 
area (anterior hypothalamus), including anteroventral periventricular, arcuate, and medial 
preoptic nuclei. 
A major role in regulating the functional activity of GnRH neurons is played by 
catecholamines, primarily by dopamine and noradrenaline delivered by afferent fibers from 
the hypothalamic periventricular nucleus and brain stem. A long known fact is that 
noradrenaline coming from the brain stem is a "releasing factor" for the preovulatory GnRH 
surge. As shown in sheep, the noradrenergic neurons A1 and A2 projecting to the bed 
nucleus of stria terminalis carry receptors for estradiol and can directly or indirectly 
influence GnRH secretion (Pereira et al., 2010). It is also known that the seasonal inhibition 
of GnRH synthesis in the sheep hypothalamus is directly correlated with activation of 
dopaminergic neurons A15. The synthesis of dopamine by neurons of this group is 
intensified under the effect of gamma-aminobutyric acid (GABA)- and glutamatergic 
neurons of the ventromedial preoptic area and ventromedial and arcuate nuclei containing 
receptors for estradiol (Goldman et al., 2010). The majority of studies on the innervation of 
GnRH neurons by catecholaminergic terminals have been performed on rats and sheep 
Tillet et al, 1993). Using electron microscopy and stereotactic surgery, their authors have not 
only revealed the fact of such innervation but also made attempts to identify the origin of 
these catecholaminergic terminals. In rats, the noradrenergic system appears to innervate 
mainly the bodies of GnRH neurons in the septo-preoptic region, while the dopaminergic 
system innervates both the bodies of these neurons and their terminals in the organum 
vasculesum of lamina terminalis (OVLT) and median eminence. In sheep, unlike in rats, the 
bodies of GnRH neurons in the septo-preoptic region are innervated mainly by 
noradrenergic fibers from the locus coeruleus and brain stem, whereas their terminals in the 
median eminence are innervated by the dopaminergic system of the hypothalamus. 
Catecholamines exert their effect through receptors expressed on the surface of GnRH 
neurons (Hosny & Jennes, 1998). 
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As noted above, various neurotransmitters and neuropeptides (monoamines, neuropeptide 
Y, opioids, etc.) are involved in the transmission of signals from external stimuli that have 
an effect on the state of the reproductive system. Thus, long-term stress induced by electric 
shock results in the inhibition of GnRH expression in the hypothalamus, and this effect is 
jointly mediated by the opioidergic, noradrenergic, and serotonergic systems 
(Ciechanowska et al., 2007). It has been shown that steroid-dependent control of GnRH 
neurons is also accounted for by other factors, including GABA, somatostatin and kisspeptin 
(Pillon et al., 2004; Oakley et al., 2009).  
Stimulation of the immune system by inflammatory bacterial endotoxins also inhibits the 
activity of the GnRH system in adult animals (Karsch et al., 2002). In the course of 
inflammation, immune system cells produce various pro- and antiinflammatory cytokines 
that activate the cascade of hormone secretion in the hypothalamo-pituitary system, thereby 
inducing the hormonal stress response. Bacterial endotoxins are often used in laboratory 
experiments as activators of the immune system. In particular, this concerns the 
lipopolysaccharide (LPS) from the outer membrane of Gram-negative bacteria, which is 
known as a factor stimulating the synthesis and secretion of pro- and antiinflammatory 
cytokines not only at the periphery but also in the CNS. Endothelial cells forming the 
hematoencephalic barrier have binding sites for LPS and its complex with accessory proteins 
(Singh & Jiang, 2004). Under the effect of LPS, these cells, along with cells of the immune 
system, can synthesize proinflammatory cytokines such as IL-1ǂ, IL-1ǃ, and IL-6; tumor 
necrosis factor alpha (TNFǂ); regulatory cytokine IL-10; and granulocyte/macrophage 
colony-stimulating factor (GM-CSF). Bacterial inflammation is also accompanied by an 
increase of another proinflammatory cytokine, the leukemia inhibitory factor (LIF) in the 
blood level, which penetrates the hematoencephalic barrier via a special transport system 
(Pan et al., 2008). Thus, bacterial inflammation stimulates signal transmission through 
vascular endothelium and cytokine transport through the hematoencephalic barrier. These 
cytokines act upon the GnRH system either directly or by inducing the synthesis or 
secretion of prostaglandins, neuropeptides, and catecholamines (Karsch et al., 2002).  
Among cytokines mediating the effect of LPS on the GnRH system, the main role is played by 
IL-1ǃ and TNFǂ. During bacterial inflammation, both these cytokines are almost equally 
effective in inhibiting the secretion of GnRH and, therefore, of the luteinizing hormone 
(Watanobe & Hayakawa, 2003). Injection of IL-1ǃ into the rat brain ventricles markedly 
reduces both the synthesis of GnRH in the septo-preoptic region and the secretion of this 
hormone, which leads to disturbances of the estrous cycle (Kang et al., 2000). Moreover, IL-1ǃ 
inhibits the expression of the c-fos protein in the nuclei of GnRH neurons, thereby altering 
GnRH synthesis during proestrus in rats. The role of IL-6 in GnRH secretion is as yet unclear. 
According to some publications, IL-6 inhibits the secretion of this hormone by neurons, 
whereas others conclude that IL-6 has no such effect even at high concentrations. However, it 
was shown, that LPS also stimulates the secretion of IL-6 in the preoptic area, which is 
followed by a drop in GnRH level within 30 min (Watanobe & Hayakawa, 2003). GM-CSF can 
also inhibit GnRH secretion in the mediobasal hypothalamic region by stimulation of GM-CSF 
receptors expressed on GABAergic neurons. Activation of these receptors leads to increased 
production of GABA, which influence on specific receptors on GnRH terminals and thereby 
inhibits NO synthase activity; as a result, the level of GnRH decreases (Kimura et al., 1997). 
The direct involvement of proinflammatory cytokines in the regulation of GnRH secretion 
has been demonstrated on the model of the immortalized GnRH-expressing neuronal cell 
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line Gnv-4 derived from the rat hypothalamus. These cells have been shown to carry 
receptors for IL-1ǃ and the accessory protein necessary for its activation as well as for the ǂ 
chain of IL-6 and the ǃ chain of oncostatin M, a functional analog of LIF participating in 
inflammatory processes (Igaz et al., 2006). Numerous data are also available on indirect 
effects of LPS and interleukins on GnRH secretion. In particular, it has been shown that IL-
1ǃ blocks nitric oxide (NO)-induced GnRH secretion in the mediobasal region of the 
hypothalamus, which, in turn, blocks the pulse secretion of the luteinizing hormone into 
circulation; as a result, the sexual behavior regulated by GnRH is suppressed (McCann et al., 
2000). Similar to GM-CSF, IL-1ǃ blocks GnRH release from the axons of GnRH by inhibiting 
NO synthase activity (Rettori et al., 1994). It also inhibits GnRH secretion induced by 
noradrenaline. Thus, in experiments with perfused fragments of the mediobasal 
hypothalamic region, the level of GnRH secretion proved to decrease when IL-1ǃ was added 
to the incubation medium together with noradrenaline (Rettori et al., 1994). The suppression 
of GnRH secretion by LPS can also be mediated by opioids (He et al., 2003). Therefore, 
activation of the immune system in response to bacterial infection entails a complex of 
reactions in the neuroendocrine system that result in the suppression of female reproductive 
function.  
2.3.2 Neuroendocrine and immune regulatory mechanisms in the development of 
GnRH system  
During early embryonic development, GnRH neurons originate in the olfactory placodes, 
wherefrom they migrate rostrocaudally, toward the forebrain, along terminal, vomeronasal, 
and olfactory nerves. Entering the brain, these neurons reach their definitive location and 
begin to form axonal connections with circumventricular organs. The process of their 
migration to the brain can be divided into three stages: intramesenchymal migration from 
the olfactory placodes to the cribriform plate of the ethmoid bone, penetration through this 
plate into the brain, and intracerebral migration to the septo-preoptic hypothalamic region. 
The general pattern of development of the GnRH system is common to most mammals, 
although the timing of formation and migration of its neurons varies between species 
depending on the duration of pregnancy and the degree of maturity at birth. In particular, 
GnRH neurons in mice are formed on day 11, and in rats, on days 12–14 of intrauterine 
development. 
In the past two decades, many attempts have been made to reveal factors influencing the 
migration and differentiation of GnRH neurons. The main factors identified to date are the 
neural cell adhesion molecule (NCAM), which forms a substrate for migrating GnRH 
neurons, and peripherin, a member of the intermediate filament protein family (Fueshko & 
Wray, 1994). Disturbances of GnRH neuron migration caused by the absence of NCAM are 
responsible for the Kallmann syndrome in humans, which involves hypogonadism and 
anosmia. Other factors influencing the development of the GnRH system include 
chemoattractants and chemorepellents such as netrin, ephrin, and semaphorin 4D 
(Schwarting et al., 2007; Giacobini et al., 2008); neurotransmitters produced by the 
microenvironment of migrating GnRH neurons (GABA, serotonin, and catecholamines), 
which regulate the rate of their migration (Bless et al., 2000; Izvolskaia et al., 2009); and 
growth factors, including the fibroblast growth factor (FGF), brain-derived neurotrophic 
factor (BDNF), hepatocyte growth factor/scatter factor (HGF/SF), and LIF (Cronin et al., 
2004; Chung et al., 2008).  
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The migration of GnRH neurons in the nasal region of rats is confined to the bundles of 
nerve fibers expressing polysialylated forms of NCAM (PSA-NCAM). Experiments on the 
removal of NCAM from this migration route (by gene knockout, enzyme treatment, or anti-
NCAM antibodies) have shown that such disturbances entail significant reduction in the 
number of migrating neurons but do not completely block their migration. On this basis, it 
has been concluded that NCAM does not play the key role in the migration of GnRH 
neurons, although is involved in the formation of their migration route. Moreover, nerve 
fibers on the migration route of rat GnRH neurons in the nasal region also express other cell 
adhesion proteins, TAG-1 and CC-2. In mice, their migration in this region is connected with 
the bundles of nerve fibers expressing peripherin (Fueshko & Wray, 1994).  
The development of the olfactory system proceeds with the involvement of numerous 
guiding molecules, in particular, chemoattractants, chemorepellents, and chemotrophic 
factors. The last group includes proteins such as Slit, semaphorins, and netrins, which 
provide directional and positional cues for growing axons of olfactory nerves and, 
supposedly, for GnRH neurons migrating in the nasal region and forebrain. The latter 
apparently pertains to netrins, a small family of secreted proteins involved in the formation 
of many nerve bundles in the brain. The receptor protein for netrins, DCC, has been 
identified and shown to be expressed in parallel to GnRH in normal mice and rats and also 
in mice with the DCC gene knockout. The DCC protein is present in peripherin-expressing 
nerve fibers guiding the migration of GnRH neurons in the nasal region, and its mRNA can 
also be detected in some GnRH neurons located in the nasal region but disappears after they 
enter the brain. Their migration in the nasal region is also guided by one more 
chemoattractant protein, HGF/SF, with its receptor protein (c-Met) being expressed in the 
immediate vicinity of migrating GnRH neurons (Giacobini et al., 2002). 
The migration rate of GnRH neurons is regulated by neurotransmitters. Many 
neurotransmitters controlling the functions of the GnRH system in adults can also provide 
spatiotemporal cues to migrating GnRH neurons during development. In particular, 
penetration of these neurons to the forebrain is guided by GABA. GABAergic neurons 
found in the nasal region of mouse, rat, and human fetuses are derived from the epithelium 
of olfactory placodes, as are GnRH neurons. Their axons extend to the cribriform plate of the 
ethmoid bone, where they can interact with GnRH neurons located there. Injection of GABA 
receptor antagonists in pregnant mice retards the migration GnRH neurons (Bless et al., 
2000). In chick embryos, a natural decrease in the rate of their migration in the zone of 
cribriform plate has been observed. The role of this phenomenon is unclear. It may be that 
the delay in migration is necessary for maturation of GnRH neurons or reorganization of 
their migration behavior prior to entering the forebrain. The migration of GnRH neurons in 
the forebrain is also guided by GABA. Injection of pregnant females with bicuculline, a 
GABA receptor antagonist, results in deviation of these neurons from the caudal segments 
of their migration route formed by peripherin-expressing fibers, with consequent 
disturbances in the pattern of their distribution in the forebrain (Bless et al., 2000). 
Glutamate is another neurotransmitter producing an effect on the migration of GnRH 
neurons. Mechanisms of this effect in the nasal region and forebrain appear to be different. 
Blockade of AMPA glutamate receptors in mice retards penetration of GnRH neurons to the 
forebrain (Simonian & Herbison, 2001), but no such receptors have been found on these 
neurons in the nasal region. In the forebrain, the effect of glutamate is apparently mediated 
by a different type of receptors. This follows from the fact that GnRH neurons of mouse 
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fetuses have been found to contain NMDAR1 glutamate receptors and that prenatal 
blockade of these receptors accelerates the migration of GnRH neurons in the forebrain 
(Simonian & Herbison, 2001). The question as to the mechanisms of glutamate action on 
these neurons remains open.  
The migration of GnRH-neurons to the definitive location in the septo-preoptic region is 
stimulated also by monoamines. Data on the distribution of GnRH neurons and the level of 
GnRH in the rostral brain region and hypothalamus of 21-day rat with chronic serotonin 
deficiency provide a basis for the conclusion that the migration of GnRH neurons is 
stimulated by serotonin (Pronina et al., 2001). The stimulating effect of serotonin is 
potentiated by testosterone, since it is better manifested in males than in females. 
During the "preneurotransmitter" period of brain development, catecholamines function as 
highly effective morphogenetic factors influencing differentiation and migration of target cells. 
In mice, dopamine appears on day 10, and noradrenaline and adrenaline, on day 11 of 
embryonic development. In rats, the first neurons expressing tyrosine hydroxylase (TH) and 
catecholamines have been found on embryonic day 13 both in the midbrain  and sympathetic 
ganglia. The migration  of GnRH neurons to the forebrain in rats on embryonic days 16–18 
coincides with the arrival of growing catecholaminergic afferent fibers to their target neurons 
in this brain region, i.e., with the appearance of an additional, local source of catecholamines. 
There is evidence that embryonic GnRH neurons and other topographically close neurons 
transiently expressing TH may also be involved in local metabolism of catecholamines. 
According to our data, suppression of catecholamine synthesis in rat embryos by alpha-
methyl-p-tyrosine (ǂMPT, a competitive TH inhibitor) beginning from day 11 of 
development leads to an increase in the number of GnRH neurons in the rostral segments of 
their migration route by day 17 and their accumulation in the zone of their entry into the 
forebrain by days 18–21 (Izvolskaia et al., 2009). 
Experiments with double immunohistochemical labeling allowed us to determine the 
regions of interaction of the catecholaminergic brain systems with migrating and 
differentiating GnRH neurons. The close topographic location of GnRH-immunoreactive 
neurons and TH-immunoreactive nerve fibers was observed in the nucleus accumbens on 
days 17 and 20 and in the median eminence on day 20.  
A quantitative radioimmunoassay for GnRH in the caudal regions of the GnRH neuron 
migration route in 21-day rat fetuses showed that injection of ǂMPT resulted in a drop of 
GnRH level in the anterior hypothalamus of female fetuses (Izvolskaia et al., 2009). This is 
additional evidence that catecholamines contribute to the regulation of development of 
GnRH neurons during prenatal ontogeny.  
Probable mechanisms of the stimulating effect of catecholamines on the migration of 
differentiating GnRH neurons may involve regulation of the exchange of calcium ions, since 
the rate of their migration depends on the intracellular concentration of these ions. In mice, 
retardation of GnRH neuron migration at the cribriform plate of the ethmoid bone takes 
place against the background of sharp increase in intracellular calcium under the effect of 
tonic depolarization of GABAergic neurons (Bless et al., 2000). In the case of differentiating 
GnRH neurons, noradrenaline is apparently a signal molecule that reduces the level of 
GnRH secretion and probably causes cell membrane hyperpolarization. This 
neurotransmitter can serve as a functional antagonist of GABA and, acting upon previously 
depolarized GnRH neurons entering the brain through the cribriform plate, contribute to the 
maintenance of intracellular calcium level, thereby stimulating the migration of GnRH 
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neurons. It is also possible that catecholamines exert an indirect effect on the migration of 
these neurons by acting on their immediate cellular environment, in particular, on 
GABAergic neurons and cells synthesizing cell adhesion molecules. However, there is no 
evidence that GABAergic neurons migrating together with GnRH neurons are innervated 
by catecholaminergic nerve fibers and express catecholamine receptors. It is also less 
probable that the effect of catecholamines is mediated via regulation of the metabolism of 
cell adhesion molecules. Indeed, neither catecholamines themselves nor their antagonists 
(e.g., 6-hydroxydopamine) have influence on the synthesis of cell adhesion molecules in the 
nervous system of fetuses or adult animals (Messenger et al., 1999). On the other hand, some 
data indicate that noradrenaline partially inhibits the synthesis of ǃ-tubulin, a cytoskeletal 
protein, which may results in the reduced rate of neuron migration (Messenger et al., 1999). 
Sex-related differences in the distribution of GnRH neurons along their migration route 
manifest themselves only against the background of catecholamine deficiency. 
Special attention has been recently devoted to the influence of cytokines on differentiation of 
GnRH neurons, but relevant published data are as yet scarce. One of such cytokines is 
HGF/SF, which has mitogenic, motogenic (stimulating cell motility), and chemoattractant 
properties with respect to nerve and other cells. HGF/SF appears in the nasal mesenchyme 
of embryos on day 12 of development, with its concentration increasing toward the brain 
and its c-Met receptor being expressed on GnRH neurons. The migration of GnRH neurons 
and the growth of their axonal cones become retarded if the HGF/SF concentration gradient 
is disturbed (Giacobini et al, 2007).  
Another cytokine, LIF, exhibits a pleiotropic action during ontogeny, producing an effect on 
proliferation of primordial germ cells, differentiation of spermatocytes, blastocyst 
implantation, and the development of the pituitary and olfactory system . Experiments with 
the immature GnRH neuronal cell line GN11 have shown that LIF can induce hemokinesis 
of these cells. Both LIF and its receptor (LIFǃ) are expressed in the nasal region of mouse 
embryos on day 13 of development, indicating a role for this cytokine in the migration of 
GnRH neurons.  
The macrophage chemotactic protein-1 (MCP-1) is a powerful chemoattractant for many 
immune and nonimmune cells. Its main function is to guide the migration of leukocytes 
from hematopoietic organs to inflammation foci. As found recently, MCP-1 also stimulates 
migration of nervous stem cells in rats. Experiments with immortalized neuronal cell lines 
GT1-7 and GN11 and in vivo studies have shown that GnRH neurons themselves produce 
MCP-1 and express receptors for his factor, while MCP-1 has a stimulating effect on their 
migration in culture (Chattopadhyay et al, 2006). 
The above facts suggest that the development of GnRH neurons and the hypothalamo–
pituitary–gonadal system as a whole is apparently subject to dramatic changes upon 
activation of the mother's immune system during pregnancy. This assumption is confirmed 
by recent data on the effect of LPS on fetal brain development. It has been shown that LPS 
induces the synthesis of the vascular endothelial growth factor, nerve growth factor (NGF), 
antiapoptotic protein YB-1, neuronal differentiation factor (necdin), and BDNF in the fetal 
rat brain cortex (Liverman et al., 2006). On day 18 of embryonic development in mice, LPS 
suppresses the expression of factors involved in neuron migration and axonal cone growth, 
namely, of semaphorin 5b and chromatin-associated Groucho protein (Liverman et al., 
2006). In addition, LPS increases the content of glial fibrillary acidic protein (GFAP), an 
intermediate filament protein, in hippocampal and cortical astrocytes and reduces the 
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content of myelin and immunoreactivity of the microglia in the offspring of LPS-injected 
rats during postnatal development. Intrauterine infection of LPS in rats results in an 
elevated level of GFAP in the brain white matter and hippocampus on postnatal day 7 and 
in the brain cortex and corpus callosum on postnatal day 14 (Yu et al., 2004). Chronic 
endotoxin-induced inflammation processes in the brain cause lesions in the white matter of 
pups examined on postnatal days 1 and 7, with these pups also showing a high level of 
GFAP expression on postnatal days 1 and 3 followed by active proliferation and 
differentiation of astrocytes (astrogliosis), on day 7 (Rousset et al., 2006). 
Prenatal activation of the immune system by endotoxins  modifies the stress response of the 
hypothalamo-pituitary system, the expression of proinflammatory cytokines in the brain, 
and the functioning of dopamin- and serotonergic systems (Wang et al., 2009). All these 
changes affect brain development, increasing the risk for neurological and mental disorders 
in remote periods. Induction of mother's immune response by LPS leads to changes in the 
levels of cytokines in different organs of the fetus. Proinflammatory cytokines are regarded 
as a connecting link between intrauterine infection during pregnancy and subsequent 
disturbances of brain functions in the fetus. Injection of LPS to pregnant mice induces 
increased expression of TNFǂ, IL-1ǃ, and MCP-1 in fetuses (Liverman et al., 2006). In rats, 
the expression of TNFǂ is observed as early as 1 h after LPS injection and its level remaining 
unchanged for 24 h, while the level of IL-1ǃ gradually decreases. The highest level of TNFǂ 
and IL-1ǃ expression is observed during the first postnatal days. During intrauterine 
infection, cytokines TNFǂ и IL-1ǃ appear to affect mainly the white matter of the fetal brain, 
which entails the development of cerebral palsy in newborn pups and characteristic 
symptoms of schizophrenia in remote periods (Yu et al., 2004). 
Prenatal infection also affects the dopaminergic system of the fetus. In pregnant rats injected 
with LPS on day 11 of pregnancy, postnatal offspring are characterized by reduced numbers of 
dopaminergic neurons, increased activity of microglia, and a high level of proinflammatory 
cytokines, especially TNFǂ, in the substantia nigra. It is considered that, что LPS suppresses 
the secretion of glutathione (an antioxidant) in glial cells, which leads to the death of 
dopaminergic neurons and the development of Parkinson's disease. As shown recently, 
prenatal LPS infection in rats results in the attrition of dopaminergic neurons in the substantia 
nigra and serotoninergic neurons in the locus coeruleus, with consequent decrease in the 
contents of dopamine and serotonin in postnatal offspring (Wang et al., 2009). Such infection 
of pregnant rats can probably affect differentiation of monoaminergic neurons not only in the 
brain stem but also in other regions of the fetal brain, including the hypothalamus.  
Initial data are also available on the effect of LPS on the GnRH system of newborn rat pups 
(Li et al., 2007). Stimulation of their immune system on the first postnatal days results in 
long-term sensitization of the GnRH system and its vulnerability to the inhibitory effect of 
stress in adult age. This effect is mediated by corticotropin-releasing hormone and its 
receptors in the median preoptic region.  
According to our data, a single LPS injection to pregnant rats on day 12 of pregnancy 
suppresses the migration of GnRH neurons, whereas such an injection on day 15 has no 
effect on their distribution along the migration route (Fig. 3). After the injection on day 12 
(but not on day 15), the total number of GnRH-immunoreactive neurons in the fetus was 
decreased on day 17 but returned to the normal (control) level by day 19. The effect 
observed on day 17 can be explained either by a general reduction of GnRH synthesis in 
these neurons or by a delay in the onset of their differentiation. In rats, GnRH neurons begin 
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to synthesize this hormone on day 15, i.e., one or two days after their formation, and the 
levels of LPS-induced cytokines in mother's blood and fetal tissues remain high only during 
24 h after injection and then return to the baseline (Liverman et al., 2006). Therefore, the 
decrease in the numbers of fetal GnRH neurons observed on day 5 after LPS injection is 
unlikely to result from the direct influence of proinflammatory cytokines on GnRH 
synthesis in these cells. However, their indirect influence cannot be excluded, IL-1ǂ and 
GM-CSF in adult animals block the release of GnRH from the axons of GnRH neurons by 
inhibiting the activity of NO synthase (Rettori et al., 1994). In view of these and our data, the 
most probable explanation is that LPS delays the onset of differentiation of GnRH neuron 
precursors. It should be noted that the total number of GnRH neurons returns to the norm 
by birth, but this does not exclude the occurrence of disturbances in the GnRH system 
functions during later periods of postnatal ontogeny. 
Stimulation of the immune system in pregnant females by LPS on day 12 results to the 
suppression of not only differentiation but also migration of fetal GnRH neurons, which 
manifests itself in the increased numbers of these cells accumulating in the rostral brain 
regions, compared to the control (Fig. 1). On the other hand, LPS injection on day 15 does 
not lead to redistribution of GnRH-immunoreactive cells along their migration route by day 
17 or 19. Thus, as GnRH cell differentiation is delayed, the start of migration of GnRH 
neurons shifts to later dates, and the rate of their intramesenchymal (intranasal) migration is 
retarded. On the other hand, LPS has no effect on the rate of their migration at later stages, 
when GnRH neurons pass through the cribriform plate of the ethmoid bone to the forebrain.  
 
  
Fig. 1. Distribution of GnRH neurons in different areas of their migration in (A) 17-day and 
(B) 19-day rat fetuses  injected with saline (control) or LPS on embryonic days (E) 12 and 15, 
m ± SD (E12: saline, n=6; LPS, n=6; E15: saline, n=3; LPS, n=3): N, nasal region; OB, olfactory 
bulbs; (B) brain. (*) Differences between the indicated values are significant at p < 0.05.  
It is during the intramesenchymal migration that GnRH neurons express receptors for 
cytokines, primarily for IL-6 and LIF (Dozio et al., 2009), while their migration within the 
brain is apparently regulated by a different mechanism. 
In the experiments described above, the migration of GnRH neurons within the nasal region 
appeared to be regulated via LPS-induced activation of the synthesis of proinflammatory 
cytokines. Therefore, we decided to analyze the effect of LPS at low doses (causing no more 
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than 25–30% fetal mortality) on the levels of cytokines IL-6, TNFǂ, LIF, and MCP-1 in 
pregnant mice and fetuses. Pregnant females were intraperitoneally injected with LPS (45 
μg/kg body weight), and cytokines in the blood sera of females and fetuses and in fetal 
cerebrospinal and amniotic fluids were determined by means of flow cytometry and ELISA. 
The results showed that the blood levels of antiinflammatory cytokines in LPS-injected 
females were increased drastically, compared to the control: the increase was 38-fold for LIF, 
28-fold for IL-6, 23-fold for MCP-1, and 20-fold for TNFǂ (Fig. 2). In fetuses, MCP-1 and IL-6 
in tissues were increased by factors of two and seven, respectively, and LIF in the amniotic 
fluid was increased threefold. Thus, activation of the immune system by LPS in pregnant 
females has proved to result in elevated levels of proinflammatory cytokines in their 
peripheral blood and then in fetuses, with consequent disturbances in the migration and 
differentiation of GnRH neurons. The strongest effect on the migration of these neurons is 
apparently characteristic of IL-6, LIF and MCP-1. 
  
 
Fig. 2. Serum concentrations of proinflammatory cytokines in 12-day mouse fetuses 1.5 in 
12-day mouse 1.5 hours after injection of saline (control) or LPS to the mother, m ± SD 
(saline, n = 6; LPS, n = 5). Abbreviations: IL-6, interleukin 6; LIF, leukemia inhibitory factor; 
MCP-1, macrophage chemotactic protein-1; TNF, tumor necrosis factor alpha. (*) Differences 
from the control are significant at p < 0.05. 
2.3.3 Role of thymic peptides in reproductive system development and functioning  
The thymus, being the primary organ of the immune system, can also be regarded as an 
endocrine organ. Moreover, it contains cells of neural origin that synthesize neuropeptides, 
which is evidence for its obvious relation to the nervous system. The thymus is the 
lymphoepitelian organ formed at the earliest stages of ontogeny. Its development begins on 
embryonic day 10 in rodents and embryonic week 4 in humans. Embryonic T-cell precursors 
migrate into thymus from the yolk sac, para-aortic splanchnopleura, and embryonic liver; in 
the postnatal period, the source of precursor cells is the bone marrow. Several systems of 
humoral regulatory factors operate in the thymus, including thymic peptides, hormones, 
neuropeptides, and cytokines. Their basic role is to provide for and regulate the 
development and functioning of T lymphocytes and thymic stroma and to control processes 
in the peripheral compartments of the immune and, probably, neuroendocrine systems 
(Goya et al, 2004). 
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A special place in thymus endocrinology belongs to thymic peptides, or hormones, which 
are relatively specific for this organ. These hormones, synthesized by epithelial cells of the 
thymus and released into the circulation, are distinguished into a separate group for the 
reason of their local synthesis (in the thymus) and sphere of action confined to the immune 
system. However, there is evidence for the synthesis of these peptides (except for thymulin) 
beyond the thymus and, in particular, in the nervous system (Hannappel et al., 2007). 
Thymic peptides appear to be cofactors in processes related to differentiation of thymocytes 
as well as to regulate the production of other hormones, neuropeptides, and cytokines in the 
thymus, hypothalamus, and pituitary. They are also involved in T-cell differentiation in the 
secondary lymphoid organs and in interactions with the hypothalamo–pituitary–adrenal 
and reproductive systems (Goya et al, 2004).  
The thymus has a significant role in the functioning of the reproductive system (Fig.3). 
Thymic peptides, primarily ǂ- and ǃ-thymosins and thymulin, stimulate GnRH secretion in 
the mediobasal hypothalamus and gonadotropin secretion in the pituitary of female rats 
(Garcia et al., 2005). In male rats, prepubertal thymectomy is followed after 45 days by a 
drop of FSH and a rise of luteinizing hormone and testosterone levels in the peripheral 
blood.  
In perinatal ontogeny, the thymus is indispensable for the formation of the pituitary-
gonadal axis. Prenatal thymectomy in primates and neonatal thymectomy in rats or mice 
result in suppressed oogenesis, reduced weights of the ovaries and adrenals, and decreased 
levels of gonadotropins in the pituitary and circulating blood during postnatal life 
(Farookhi, 1988). Disturbances in the immune system manifest themselves 25–30 days after 
thymectomy. In particular, thymectomy on postnatal day 3 leads to the paucity of 
regulatory T cells, loss of peripheral tolerance, and development of organ-specific 
autoimmune disease in adult mice. Moreover, it induces production of auto-oocyte 
antibodies detectable in the circulation, with consequent development of autoimmune 
ovarian dysgenesis. Importantly, day 3 thymectomy does not necessarily lead to 
autoimmune disease in all mouse strains, indicating that processes responsible for the 
disease development are genetically controlled (Roper et al., 2002).  
Neonatal thymectomy also affects the male reproductive system, but its consequences 
manifest themselves relatively late. A drop in the levels of luteinizing hormone and 
prolactin takes place on days 60–90 after thymectomy, and symptoms observed on days 13-
170 include testicular atrophy, hypertrophy of pituitary ǃ-cells, and lymphoid infiltration of 
the pituitary, thyroid, and prostate (Farookhi, 1988). It should be noted that thymectomy on 
postnatal day 10 also results in retarded sexual development (with reduced numbers of 
follicles, low levels of blood estrogens, etc.), as does neonatal thymectomy. Thymulin 
corrects these disturbances, while in normal mice it has no effect on estrogen secretion 
(Goya et al, 2004; García et al., 2005).  
In mutant nude (athymic) mice, disturbances are observed not only in the immune system 
but also in the neuroendocrine and reproductive systems. Embryonic development of the 
thymus in these mice is controlled by gene Foxn1 located on chromosome 11. It proceeds 
normally until embryonic day 11, when the complex architecture of the thymus becomes 
distorted, which interferes with differentiation of thymic epithelial cells and colonization of 
the organ by lymphoid precursor cells. Changes in the reproductive system of athymic 
mutants are similar to those in neonatally thymectomized mice. 
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Fig. 3. Interactions of the GnRH system with the hypothalamo–pituitary–gonadal axis and 
immune system. Abbreviations: GnRH, gonadotropin releasing hormone-producing 
neurons; LH, luteinizing hormone; FSH, follicle stimulating hormone; LC, locus coeruleus; 
A1, A2, and A15, catecholamine-producing  (tyrosine hydroxylase-immunoreactive) cell 
groups in the brain.  
Acidophilic and basophilic pituitary cells in the mutants are smaller than normal, and the 
synthesis of the growth hormone, prolactin, FSH, and luteinizing hormone is reduced (Goya 
et al, 2004). Thymic peptides, thymulin in particular, correct these disturbances (García et 
al., 2005). Neonatal thymulin gene therapy in nude mice results in normalization of blood 
thymulin and gonadotropin levels at maturity (Goya et al., 2007). Thus, the hormonal 
hypofunction of the thymus during early ontogeny entails long-term or irreversible 
disturbances in the structure and functions of both immune and reproductive systems. 
The sum of available data suggests the following scheme of interactions between the 
hypothalamo-pituitary reproductive system and the thymus (Fig. 3). Hypothalamic GnRH 
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interacts with specific receptors on epithelial cells of the thymus, thereby inducing the 
synthesis of thymic peptides by these cells and differentiation of T lymphocytes, the latter 
process involving participation of thymic GnRH and sex hormones. Thymic peptides, in 
turn, stimulate the secretion and functional activity of hypothalamic GnRH, which induces 
the secretion of gonadotropins and thereby modulates steroidogenesis. 
3. Conclusion  
The data considered in this review demonstrate that interactions of the hypothalamo–
pituitary–gonadal and immune systems are a lifelong phenomenon that begins during 
embryonic development. The pattern of establishment and development of their interactions 
during early ontogeny is a major factor in programming the health of an individual. 
Changes in these systems upon perinatal exposure to various adverse factors upset the 
normal homeostatic balance of the body, causing disturbances in their functioning 
throughout the subsequent life span. The plasticity of physiological systems during early 
ontogeny provides for effective adaptation of the developing organism to variable ambient 
conditions; on the other hand, it is responsible for long-term or even permanent alteration of 
general response to environmental factors. Thus, thymic peptide deficiency in neonatally 
thymectomized or nude mice or increased levels of proinflammatory cytokines resulting 
from bacterial infection in a pregnant female cause disturbances in the formation of various 
brain systems, thereby affecting differentiation of GnRH neurons and, therefore, the 
establishment of the reproductive function. Since high concentrations of sex steroids can 
significantly intrude on the formation of the neuroendocrine–immune axis, caution should 
be taken in prescribing sex steroids and their synthetic analogs. In particular, this concerns 
prenatal treatment with estriol recommended by some specialists. Special attention should 
also be given to the children whose mothers suffered an infectious disease during 
pregnancy. On the other hand, experimental and clinical data accumulated to date provide 
evidence for a favorable effect of estrogens on patients with autoimmune diseases, e.g., 
multiple sclerosis. 
The patterning of sexual behavior of sex steroids takes place not only during early 
development: these hormones can alter the prenatal programming of relevant systems at 
later stages of ontogeny, with adolescence being most responsive to their influence. The 
effects of GnRH and sex hormones on the immune system during adult life are apparently 
nonspecific and serve to maintain its homeostasis in response to changes in ambient 
conditions or to stress-induced immunosuppression. Indeed, thymocyte deficiency resulting 
from age-related thymus involution or stress can be reversed by treatment with hormones, 
including GnRH and its agonists. 
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